TERN
Terns Pharmaceuticals, Inc. · Healthcare
CEO Amy L. Burroughs sold $2.5M of Terns Pharmaceuticals, Inc.
Sold$2,548,603
$37.07Price
68,749Shares
−19%Stake
What TERN did after the filing
- The stock from Tue, Jan 20 open, $35.52
- +19.7%
- S&P 500, same days
- +0.5%
Measured over 30 trading days, to the Mar 4 close.
Traded Thu, Jan 15. Filed Fri, Jan 16, 5:22 PM ET, after the close. Returns use the Jan 20 open and the Mar 4 close. Not investment advice.